SEC Acceleration Request (5-17-2018)

May 17, 2018

 

Via EDGAR 

 



 

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549-3720

Attention:

Amanda Ravitz



Heather Percival



 

 

 

 



Re:

Pulse Biosciences, Inc.



 

Registration Statement on Form S-3



 

Filed May 17, 2018



 

File No. 333-224800

Acceleration Request





 

 



Requested Date:

May 21, 2018



Requested Time:

4:00 PM Eastern Time



Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Pulse Biosciences, Inc. (the “Company”) hereby requests that the above-referenced Registration Statement on Form S-3 (File No. 333-224800) (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above or as soon thereafter as practicable, or at such later time as the Company may request by telephone to the staff (the “Staff”) of the Securities and Exchange Commission (the “Commission”). The Company hereby authorizes Andrew D. Hoffman of Wilson Sonsini Goodrich & Rosati, Professional Corporation, counsel for the Company, to make such request on the Company’s behalf.

The Company requests that it be notified of the effectiveness of the Registration Statement by telephone to Andrew D. Hoffman of Wilson Sonsini Goodrich & Rosati, Professional Corporation, at (650) 849-3240.  

Please direct any questions or comments regarding this acceleration request to Andrew D. Hoffman at (650) 849-3240.

 

*****


 

Securities and Exchange Commission

Re: Pulse Biosciences, Inc.

May 17, 2018

Page 2

 

 



 

 



Sincerely,



 

 



PULSE BIOSCIENCES, INC.



 

 



 

 



By:

/s/ Brian B. Dow



 

Brian B. Dow



 

Senior Vice President and Chief Financial Officer

 

 



 

 



cc:

Andrew D. Hoffman, Esq.





Wilson Sonsini Goodrich & Rosati, Professional Corporation